Alkem Laboratories Ltd (BOM:539523)
₹ 5501.35 -117.95 (-2.1%) Market Cap: 658.01 Bil Enterprise Value: 629.50 Bil PE Ratio: 32.04 PB Ratio: 6.38 GF Score: 98/100

Q2 2023 Alkem Laboratories Ltd Earnings Call Transcript

Nov 11, 2022 / 11:30AM GMT
Release Date Price: ₹3171.4 (-0.19%)
Operator

Ladies and gentlemen, good day, and welcome to the Alkem Laboratories Q2 FY '23 Earnings Conference Call, hosted by Motilal Oswal Financial Services. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Tushar Manudhane. Thank you, and over to you, sir.

Tushar Manudhane
Motilal Oswal Securities Limited, Research Division - Research Analyst

Thank you, Mike. Welcome to 2Q FY '23 earnings call of Alkem Laboratories. From the management side, we have Mr. Sandeep Singh, Managing Director; Mr. Rajesh Dubey, Chief Financial Officer; Mr. Amit Ghare, President, International Business; Mr. Yogesh Kaushal, President, Chronic Division; and Amit Khandelia, AVP Finance.

Over to you, Amit, for the opening.

Amit Kumar Khandelia
Alkem Laboratories Limited - IR Officer

Thank you, Tushar. Good evening, afternoon, and thank you for joining us today for Alkem Laboratories Q2 FY '23 earnings call. Earlier during the day, we have released our financial results and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot